A detailed history of Essex LLC transactions in Amgen Inc stock. As of the latest transaction made, Essex LLC holds 825 shares of AMGN stock, worth $217,288. This represents 0.05% of its overall portfolio holdings.

Number of Shares
825
Previous 824 0.12%
Holding current value
$217,288
Previous $257,000 3.11%
% of portfolio
0.05%
Previous 0.06%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$309.38 - $337.38 $309 - $337
1 Added 0.12%
825 $265,000
Q2 2024

Jul 22, 2024

BUY
$262.75 - $319.31 $19,706 - $23,948
75 Added 10.01%
824 $257,000
Q1 2024

May 03, 2024

SELL
$268.87 - $324.56 $26,618 - $32,131
-99 Reduced 11.67%
749 $212,000
Q3 2023

Oct 16, 2023

BUY
$218.65 - $271.46 $185,415 - $230,198
848 New
848 $227,000
Q4 2022

Jan 30, 2023

BUY
$229.03 - $291.01 $193,759 - $246,194
846 New
846 $222,000
Q1 2022

Apr 20, 2022

BUY
$219.27 - $242.57 $185,283 - $204,971
845 New
845 $204,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Essex LLC Portfolio

Follow Essex LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex LLC with notifications on news.